The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
What We Know About Tuberculosis Transmission: An Overview
Open accessAbstract
Tuberculosis remains a global health problem with an enormous burden of disease, estimated at 10.4 million new cases in 2015. To stop the tuberculosis epidemic, it is critical that we interrupt tuberculosis transmission. Further, the interventions required to interrupt tuberculosis transmission must be targeted to high-risk groups and settings. A simple cascade for tuberculosis transmission has been proposed in which (1) a source case of tuberculosis (2) generates infectious particles (3) that survive in the air and (4) are inhaled by a susceptible individual (5) who may become infected and (6) then has the potential to develop tuberculosis. Interventions that target these events will interrupt tuberculosis transmission and accelerate the decline in tuberculosis incidence and mortality. The purpose of this article is to provide a high-level overview of what is known about tuberculosis transmission, using the tuberculosis transmission cascade as a framework, and to set the scene for the articles in this series, which address specific aspects of tuberculosis transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Self-citationThe Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054 · cited 1×
“tuberculosis infection has recently been reestimated at 24% [2].”
BackgroundA blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn-Nicholson, A., Scriba, T. J., Thompson, E., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 780
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Sh, F. (1970) · PubMed · Cited by 721
Contact investigation for tuberculosis: a systematic review and meta-analysis
Fox, G. J., Barry, S. E., Britton, W. J., & Marks, G. B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00070812 · Cited by 709
WELLS, W. F. (1934) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118097 · Cited by 602
Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Bara, W., Mungofa, S., Pai, M., Hoelscher, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62073-5 · Cited by 433
Self-citationEpidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Longini, I. M., Dye, C., & Halloran, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901720106 · Cited by 348
Riley, R. L., MILLS, C. C., O'Grady, F., SULTAN, L. U., Wittstadt, F. B., & Shivpuri, D. (1962) · PubMed · doi:10.1164/arrd.1962.85.4.511 · Cited by 313
RILEY, R. L., MILLS, C. C., NYKA, W., WEINSTOCK, N., STOREY, P. B., SULTAN, L. U., RILEY, M. C., & WELLS, W. F. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117542 · Cited by 269
Guerra-Assunção, J., Crampin, A., Houben, R., Mzembe, T., Mallard, K., Coll, F., Khan, P., Banda, L., Chiwaya, A., Pereira, R., et al. (2015) · eLife · doi:10.7554/elife.05166 · Cited by 257
Global tuberculosis control: lessons learnt and future prospects
Lienhardt, C., Glaziou, P., Uplekar, M., Lönnroth, K., Getahun, H., & Raviglione, M. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2797 · Cited by 250
Corbett, E. L., Bandason, T., Duong, T., Dauya, E., Makamure, B., Churchyard, G. J., Williams, B. G., Munyati, S. S., Butterworth, A. E., Mason, P. R., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61425-0 · Cited by 247
Self-citationIsoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.
Comstock, G. W., Baum, C., & Snider, D. E. (1979) · PubMed · doi:10.1164/arrd.1979.119.5.827 · Cited by 241
A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control
Churchyard, G. J., Fielding, K. L., Lewis, J. J., Coetzee, L., Corbett, E. L., Godfrey-Faussett, P., Hayes, R. J., Chaisson, R. E., & Grant, A. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1214289 · Cited by 238
Self-citationUpper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission
Escombe, A. R., Moore, D. A. J., Gilman, R. H., Navincopa, M., Ticona, E., Mitchell, B., Noakes, C., Martínez, C., Sheen, P., Ramirez, R., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000043 · Cited by 237
Ayles, H., Muyoyeta, M., Du Toit, E., Schaap, A., Floyd, S., Simwinga, M., Shanaube, K., Chishinga, N., Bond, V., Dunbar, R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61131-9 · Cited by 233
Kranzer, K., Afnan-Holmes, H., Tomlin, K., Golub, J. E., Shapiro, A. E., Schaap, A., Corbett, E. L., Lönnroth, K., & Glynn, J. R. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0743 · Cited by 226
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection
Rangaka, M. X., Cavalcante, S. C., Marais, B. J., Thim, S., Martinson, N. A., Swaminathan, S., & Chaisson, R. E. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00323-2 · Cited by 216
A controlled trial of community-wide isoniazid prophylaxis in Alaska.
Comstock, G. W., Ferebee, S. H., & Hammes, L. M. (1967) · PubMed · doi:10.1164/arrd.1967.95.6.935 · Cited by 211
Churchyard, G. J., Stevens, W. S., Mametja, L. D., McCarthy, K. M., Chihota, V., Nicol, M. P., Erasmus, L. K., Ndjeka, N. O., Mvusi, L., Vassall, A., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00100-x · Cited by 209
Self-citationTuberculosis Diagnosis — Time for a Game Change
Small, P. M., & Pai, M. (2010) · New England Journal of Medicine · doi:10.1056/nejme1008496 · Cited by 196
Houben, R. M. G. J., Menzies, N. A., Sumner, T., Huynh, G. H., Arinaminpathy, N., Goldhaber-Fiebert, J. D., Lin, H.-H., Wu, C.-Y., Mandal, S., Pandey, S., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30199-1 · Cited by 196
Self-citationThe transmission of Mycobacterium tuberculosis in high burden settings
Yates, T. A., Khan, P. Y., Knight, G. M., Taylor, J. G., McHugh, T. D., Lipman, M., White, R. G., Cohen, T., Cobelens, F. G., Wood, R., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00499-5 · Cited by 192
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
Knight, G. M., Griffiths, U. K., Sumner, T., Laurence, Y. V., Gheorghe, A., Vassall, A., Glaziou, P., & White, R. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404386111 · Cited by 190
Lawn, S. D., Wood, R., De Cock, K. M., Kranzer, K., Lewis, J. J., & Churchyard, G. J. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70078-5 · Cited by 180
Self-citationAge- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection
Dodd, P. J., Looker, C., Plumb, I. D., Bond, V. A., Schaap, A., Shanaube, K., Muyoyeta, M., Vynnycky, E., Godfrey‐Faussett, P., Corbett, E. L., et al. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv160 · Cited by 163
Cough and the Transmission of Tuberculosis
Turner, R. D., & Bothamley, G. H. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu625 · Cited by 158
Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis
Dharmadhikari, A. S., Mphahlele, M., Venter, K., Stoltz, A. C., Mathebula, R., Masotla, T., der Walt, M. L. V., Pagano, M., Jensen, P. A., & Nardell, E. A. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0834 · Cited by 149
Airborne infection : transmission and control
Riley, R. L., & O'Grady, F. (1961) · University of Michigan Library Repository · Cited by 147
Corbett, E. L., Bandason, T., Cheung, Y. B., Munyati, S. S., Godfrey‐Faussett, P., Hayes, R., Churchyard, G., Butterworth, A. E., & Mason, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0040022 · Cited by 135
Self-citationAndrews, J. R., Morrow, C. D., Walensky, R. P., & Wood, R. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu138 · Cited by 121
Modeling the Role of Public Transportation in Sustaining Tuberculosis Transmission in South Africa
Andrews, J. R., Morrow, C. D., & Wood, R. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws331 · Cited by 121
AERIAL DISSEMINATION OF PULMONARY TUBERCULOSIS A TWO-YEAR STUDY OF CONTAGION IN A TUBERCULOSIS WARD1
Rl, R., Mills, C. C., NYKA, W., WEINSTOCK, N., Storey, P. B., SULTAN, L. U., RILEY, M. C., & Wf, W. (1959) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120069 · Cited by 120
High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening
Telisinghe, L., Fielding, K., Malden, J. L., Hanifa, Y., Churchyard, G., Grant, A. D., & Charalambous, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087262 · Cited by 107
Self-citationDurovni, B., Saraceni, V., Moulton, L. H., Pacheco, A. G., Cavalcante, S. C., King, B., Cohn, S. E., Efron, A., Chaisson, R. E., & Golub, J. E. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70187-7 · Cited by 104
Prevalence of latent tuberculosis infection among gold miners in South Africa.
Hanifa, Y., Grant, A. D., Lewis, J. J., Corbett, E. L., Fielding, K., & Churchyard, G. (2009) · PubMed · Cited by 82
Self-citationZelner, J., Murray, M. B., Becerra, M. C., Galea, J. T., Lecca, L. W., Calderon, R. I., Yataco, R. M., Contreras, C. C., Zhang, Z., Manjourides, J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv387 · Cited by 81
Escombe, A. R., Huaroto, L., Ticona, E., Burgos, M., Sanchez, I., Carrasco, L. V. V., Farfán, E. M. A., Flores, F., & Moore, D. (2010) · PubMed · Cited by 62
Tuberculosis in a South African prison - a transmission modelling analysis.
Johnstone-Robertson, S. P., Lawn, S. D., Welte, A., Bekker, L., & Wood, R. (2011) · PubMed · Cited by 60
Huang, C.-C., Tchetgen, E. T., Becerra, M. C., Cohen, T., Hughes, K. C., Zhang, Z., Calderon, R. I., Yataco, R. M., Contreras, C. C., Galea, J. T., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit948 · Cited by 55
Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland.
HORWITZ, O., Pg, P., & Wilbek, E. (1966) · PubMed · Cited by 46
Transforming the Fight Against Tuberculosis: Targeting Catalysts of Transmission
Dowdy, D. W., Azman, A. S., Kendall, E. A., & Mathema, B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu506 · Cited by 45
Self-citationCommunity-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.
Cavalcante, S. C., Durovni, B., Barnes, G. L., de Souza, F. B. A., Silva, R. F., Barroso, P. F., Mohan, C., Miller, A. C., Golub, J. E., & Chaisson, R. E. (2010) · PubMed · Cited by 43
Cowie, R. L. (1996) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(96)90007-6 · Cited by 34
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
Kendall, E. A., Shrestha, S., Cohen, T., Nuermberger, E. L., Dooley, K. E., González-Angulo, L., Churchyard, G., Nahid, P., Rich, M., Bansbach, C., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002202 · Cited by 31
Self-citation
Cited by
Gopalaswamy, R., Shanmugam, S., Mondal, R., & Subbian, S. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00667-6 · Cited by 350
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 312
The Diagnosis and Treatment of Tuberculosis
Suárez, I., Fünger, S. M., Kröger, S., Rademacher, J., Fätkenheuer, G., & Rybniker, J. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0729 · Cited by 264
Pan, Z., Zhang, J., Bu, Q., He, H., Bai, L., Yang, J., Liu, Q., & Lyu, J. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s248875 · Cited by 29
Adamou Mana, Z., Beaudou, C. N., Hilaire, K. F. J., Konso, J., Ndahbove, C., Waindim, Y., Ganava, M., Malama, T., Matip, C., Meoto, P., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000301 · Cited by 5
Metadata
- Authors
- Churchyard, G., Kim, P., Shah, N. S., Rustomjee, R., Gandhi, N., Mathema, B., Dowdy, D., Kasmar, A., & Cardenas, V.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-01
- Volume
- 216
- Issue
- suppl_6
- Pages
- S629-S635
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2765354416
- Cited by
- 341
- References
- 47
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.